WHO Prequalifies First Ever Malaria Treatment for Newborns and Infants – Asrar Qureshi’s Blog Post #1259
The WHO’s approval of Coartem Baby marks a historic achievement in malaria treatment for newborns and young infants, addressing a critical gap in healthcare. Developed by Novartis and Medicines for Malaria Venture, this innovative drug provides a safer, accurately dosed option, highlighting the importance of inclusive pharmaceutical innovation and collaborative efforts in global health.